These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15888053)

  • 1. Everolimus alters the bronchoalveolar lavage and endobronchial biopsy immunologic profile post-human lung transplantation.
    Snell GI; Levvey BJ; Zheng L; Bailey M; Orsida B; Law L; Whitford HM; Kotsimbos TC; Williams TJ
    Am J Transplant; 2005 Jun; 5(6):1446-51. PubMed ID: 15888053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
    Snell GI; Levvey BJ; Zheng L; Bailey M; Orsida B; Williams TJ; Kotsimbos TC
    J Heart Lung Transplant; 2007 Jul; 26(7):669-74. PubMed ID: 17613395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathological changes in the airways of stable lung transplant recipients.
    Snell GI; Ward C; Wilson JW; Orsida B; Williams TJ; Walters EH
    Thorax; 1997 Apr; 52(4):322-8. PubMed ID: 9196513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.
    Snell GI; Valentine VG; Vitulo P; Glanville AR; McGiffin DC; Loyd JE; Roman A; Aris R; Sole A; Hmissi A; Pirron U;
    Am J Transplant; 2006 Jan; 6(1):169-77. PubMed ID: 16433771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
    Azzola A; Havryk A; Chhajed P; Hostettler K; Black J; Johnson P; Roth M; Glanville A; Tamm M
    Transplantation; 2004 Jan; 77(2):275-80. PubMed ID: 14742993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
    Eisen H
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii9-13. PubMed ID: 16815858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
    Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
    Viganò M; Tuzcu M; Benza R; Boissonnat P; Haverich A; Hill J; Laufer G; Love R; Parameshwar J; Pulpón LA; Renlund D; Abeywickrama K; Cretin N; Starling RC; Eisen HJ;
    J Heart Lung Transplant; 2007 Jun; 26(6):584-92. PubMed ID: 17543781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
    Kovarik JM; Snell GI; Valentine V; Aris R; Chan CK; Schmidli H; Pirron U
    J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar lavage in lung transplantation. State of the art.
    Tiroke AH; Bewig B; Haverich A
    Clin Transplant; 1999 Apr; 13(2):131-57. PubMed ID: 10202611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma.
    Elston WJ; Whittaker AJ; Khan LN; Flood-Page P; Ramsay C; Jeffery PK; Barnes NC
    Eur Respir J; 2004 Sep; 24(3):375-7. PubMed ID: 15358694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics and associations of airway neutrophilia post lung transplantation.
    Zheng L; Whitford HM; Orsida B; Levvey BJ; Bailey M; Walters EH; Williams TJ; Kotsimbos T; Snell GI
    Am J Transplant; 2006 Mar; 6(3):599-608. PubMed ID: 16468972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased intracellular pro- and anti-inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients.
    Hodge G; Hodge S; Reynolds PN; Holmes M
    Transplantation; 2005 Oct; 80(8):1040-5. PubMed ID: 16278583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection.
    Ward C; Snell GI; Zheng L; Orsida B; Whitford H; Williams TJ; Walters EH
    Am J Respir Crit Care Med; 1998 Jul; 158(1):84-91. PubMed ID: 9655711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.
    Kobashigawa J; Ross H; Bara C; Delgado JF; Dengler T; Lehmkuhl HB; Wang SS; Dong G; Witte S; Junge G; Potena L
    Transpl Infect Dis; 2013 Apr; 15(2):150-62. PubMed ID: 23013440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
    Valantine H; Zuckermann A
    J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.
    Zheng L; Orsida B; Whitford H; Levvey B; Ward C; Walters EH; Williams TJ; Snell GI
    Transplantation; 2005 Jul; 80(2):185-92. PubMed ID: 16041262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus in lung transplantation in Chile.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):328-30. PubMed ID: 20172343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure.
    Kovarik JM; Eisen H; Dorent R; Mancini D; Vigano M; Rouilly M; Hsu CH; Rordorf C
    J Heart Lung Transplant; 2003 Oct; 22(10):1117-25. PubMed ID: 14550821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.